What's new

Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed

Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed

Mar 28, 2025 - 16:24
 0
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed
Read More

Tags:

Previous Article

Pony.ai expands its robotaxi service in Shenzhen

Next Article

Utilities should develop data center tariffs to protect consumers, decarbonize: ...

Related Posts

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025  0

Infectious Diseases Working Party (IDWP) consolidated 3...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Spherox, spheroids of human autologous matrix-associated chondrocytes, Date of authorisation: 10/07/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0